Breast Cancer
Preclinical data published on how Panzem inhibits cell growth
Published in Women's Health Weekly, February 13th, 2003
EntreMed scientists found that Panzem, also referred to as 2-methoxyestradiol (or 2ME2), kills tumor cells and their supporting blood vessel cells by turning-on increased levels of a death receptor (Death Receptor 5 or DR5) that is located on the cell surface. In turn, this action triggers programmed cell death, or "apoptosis." DR5 may also serve as surrogate marker for assessing clinical responses to Panzem. Currently, Panzem is in phase I clinical trials for breast cancer and in...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Breast Cancer
Scientists offer conclusive proof on preventive effects of tamoxifen - Cervical Cancer
Task force supports less frequent screening for some women - Fitness
Why do women exercise less often than men? - Hip Fracture
Inhaled corticosteroids may increase risk for fracture after hip injury - Women's Health
Malacoplakia of the ovary, fallopian tube and uterus associated with diabetes - AIDS Epidemic
HIV/AIDS is leading cause of death for African American, Latinas women in Pennsylvania - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
